Short- and long-term changes in plasma inflammatory markers associated with preeclampsia

Hypertension

Volumn 44, Issue 5, 2004, Pages 708-714

  Freeman, Dilys J ^a,d   McManus, Frances ^a   Brown, Elizabeth Ann ^a   Cherry, Lynne ^a   Norrie, John ^b   Ramsay, Jane E ^a   Clark, Peter ^c   Walker, Isobel D ^d   Sattar, Naveed ^a   Greer, Ian A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cardiovascular diseases; Inflammation; Polymorphism; Preeclampsia

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; INFLAMMATION; PREECLAMPSIA; PRIORITY JOURNAL; RISK; SMOKING; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-6; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 7244255801     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000143849.67254.ca     Document Type: Article

References (47)

1. Lyall F, Greer IA. Preeclampsia: a multifaceted vascular disorder of pregnancy. J Hypertens. 1994;12:1339-1345.
2. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet. 2001;357:2002-2006.
3. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after preeclampsia: population-based cohort study. BMJ. 2001;323:1213-1217.
4. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179: 80-86.
5. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: does this indicate the mechanism of leucocyte activation? BJOG. 1994;101:173-174.
6. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines IL-6 and IL-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937-940.
7. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40: 102-111.
8. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. IL-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. BJOG. 1995;102:20-25.
9. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. AJOG. 1999;180: 499-506.
10. Rodie VA, Freeman DJ, Sattar N, Greer IA. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004; 175:189-202.
11. Ross R. Atherosclerosis -an inflammatory disease. N Engl J Med. 1999; 340:115-126.
12. Blake GJ, Ridker PMJ. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002;252:283-294.
13. Sattar N, Clark P, Holmes A, Lean ME, Walker I, Greer IA. Antenatal waist circumference and hypertension risk. Obstet Gynecol. 2001;97: 268-271.
14. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol. 2001;98:757-762.
15. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, Hingorani AD. Human CRP gene polymorphism influences CRP levels. Implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23:1-7.
16. Jiang H, Klein RM, Niederacher D, Du M, Marx R, Horlitz M, Boerrigter G, Lapp H, Scheffold T, Krakau I, Gulker H. C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction. Int J Cardiol. 2002;84:171-177.
17. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The IL-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J. 2001; 22:2243-2252.
18. Vatay A, Bene L, Kovacs A, ProhaszkaZ, Szalai C, Romics L, Fekete B, Karadi I, Fust G. Relationship between the tumour necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 2003;55:247-252.
19. Heiskanen J, Romppanen EL, Hiltunen M, Iivonen S, Mannermaa A, Punnonen K, Heinonen S. Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia. J Assist Reprod Genet. 2002;19:220-223.
20. Lachmeijer AM, Nosti-Escanilla MP, Bastiaans EB, Pals G, Sandkuijl LA, Kostense PJ, Aarnoudse JG, Crusius JB, Pena AS, Dekker GA, Arngrimsson R, ten Kate LP. Linkage and association studies of IL1B and IL1RN gene polymorphisms in preeclampsia. Hypertens Pregnancy. 2002;21:23-38.
21. Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in preeclampsia. Clin Exp Immunol. 1996;104:154-159.
22. Dizon-Townson DS, Major H, Ward K. A promoter mutation in the tumour necrosis factor α gene is not associated with preeclampsia. J Reprod Immunol. 1998;38:55-61.
23. Clark P, Sattar N, Walker ID, Greer IA. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost. 2001;85:30-35.
24. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classical and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003;42:39-42.
25. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343:1148-1155.
26. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA. 1977;74:1245-1249.
27. Cao H, Hegele RA. Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet. 2000;45:100-101.
28. Ye SQ, Usher D, Virgil D, Zhang LQ, Yochim SE, Gupta R. A PstI polymorphism detects the mutation of serine 128 to arginine in CD 62E gene -a risk factor for coronary artery disease. J Biomed Sci. 1999;6: 18-21.
29. Nejentsev S, Laine A, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens. 2000;55:568-570.
30. Mansfield JC, Holden H, Tarlow JK, Di Giovine fractional shortening (FS), McDowall TL, Wilson AG, Holdsworth CD, Duff GW. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine IL-1 receptor antagonist. Gastroenterology. 1994;106:637-642.
31. Fishman D, Faulds G, Jeffrey R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the IL 6 (1L-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102: 1369-1376.
32. Carstairs V, Morris R. Deprivation and mortality: an alternative to social class? Community Med. 1989;11:210-219.
33. Hamai Y, Fujii T, Yamashita T, Nishina H, Kozuma S, Mikami Y and Taketani Y. Evidence for an elevation in serum IL-2 and tumour necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol. 1997;38:89-93.
34. Omu AE, Al-Qattan F, Diejomach ME, Al-Yatama M. Differential levels of T helper cytokines in preeclampsia: pregnancy, labor and puerperium. Acta Obstet Gynecol Scand. 1999;78:675-680.
35. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent preeclampsia. BJOG. 2002;109: 759-764.
36. Bartha JL, Romero-Carmona R, Escobar-Llompart M, Comino-Delgado R. The relationships between leptin and inflammatory cytokines in women with preeclampsia. BJOG. 2001;108:1272-1276.
37. 1, and epithelial-cadherin in preeclampsia. Obstet Gynecol. 2002;100:327-331.
38. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol. 1999;163:3491-3495.
39. Benyo DF, Smarason A, Redman CW, Sims C, Conrad K. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001;86:2505-2512.
40. Kauma SW, Wang Y, Walsh SW. Preeclampsia is associated with decreased placental IL-6 production. J Soc Gynecol Investig. 1995;2: 614-617.
41. Takacs P, Green KL, Nikaeo A, Kauma SW. Increased vascular endothelial cell production of IL-6 in severe preeclampsia. Am J Obstet Gynecol. 2003;188:740-744.
42. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaro W, Hanefeld M. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002;51:743-749.
43. Cleland SJ, Sattar N, Petrie JR, Forouhi NG, Elliott HL, Connell JMC. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci. 2000;98:531-535.
44. Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: a link between preeclampsia and maternal coronary heart disease. BJOG. 2003;110:1029-1031.
45. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos J-C, Connelly PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001; 107:1255-1262.
46. Livingston JC, Park V, Barton JR, Elfering S, Haddad B, Mabie WC, Quasney M, Sibai BM. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumour necrosis factor α and lymphotoxin a genes and plasma tumor necrosis factor α levels. Am J Obstet Gynecol. 2001;184:1273-1277.
47. Lachmeijer AMA, Crusius JBA, Pals G, Dekker GA, Arngrimsson R, Kate LPT. Polymorphisms in the tumour necrosis factor and lymphotoxin-α gene region and preeclampsia. Obstet Gynecol. 2001;98: 612-619.